A Multidisciplinary Approach to the Management of Eales Disease: A Case Report and Review of the Literature
- PMID: 38540977
- PMCID: PMC10970779
- DOI: 10.3390/jpm14030235
A Multidisciplinary Approach to the Management of Eales Disease: A Case Report and Review of the Literature
Abstract
Eales disease manifests as an obliterative periphlebitis affecting the retina; it originates from the periphery and progresses posteriorly. It is characterized by retinal vessel wall inflammation, ischemia, and retinal neovascularization. In this report, we present the case of a 34-year-old male who attended our clinic with a sudden blurring of vision in his right eye. A diagnosis of bilateral retinal vasculitis with vitreal hemorrhage was ascertained in his RE. A dilated ocular fundus examination revealed perivenous sheathing of the peripheral vessels in both eyes. Fluorescein angiography indicated dye staining, vessel obliteration, capillary drop-out, areas of non-perfusion and the formation of new vessels. Laboratory tests revealed positive results for Borrelia; a PPD skin test and QuantiFERON TB assay were also positive. The patient underwent bilateral retinal laser pan-photocoagulation, followed by systemic treatment with oral steroids, cephazoline, isoniazid, azathioprine, and entecavir. The steroid dose was progressively reduced over 10 months; the treatment with azathioprine continues, as we are monitoring the patient over the long term. After 3 months, the vasculitis had regressed without any vitreal hemorrhage recurrence. Vision acuity improved from 0.4 to 1 in the patient's right eye. A multidisciplinary approach, which included collaborative management with gastroenterology, infectious disease, pulmonology, and rheumatology specialists, was essential for the diagnosis, treatment, and long-term follow up of the patient.
Keywords: Eales disease; Mycobacterium tuberculosis; epimacular membrane; retinal vasculitis.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





Similar articles
-
Adjuvant Intravitreal Bevacizumab for Retinal Neovascularization in Eales' Disease Associated With Latent Mycobacterium Tuberculosis.Cureus. 2023 Jun 26;15(6):e41003. doi: 10.7759/cureus.41003. eCollection 2023 Jun. Cureus. 2023. PMID: 37503481 Free PMC article.
-
Double Trouble: Eales Disease in a Background of Paradoxical Embolism.Cureus. 2023 Sep 5;15(9):e44708. doi: 10.7759/cureus.44708. eCollection 2023 Sep. Cureus. 2023. PMID: 37809206 Free PMC article.
-
Advanced Eales' Disease With Neovascular Glaucoma at First Presentation.Cureus. 2021 Sep 26;13(9):e18302. doi: 10.7759/cureus.18302. eCollection 2021 Sep. Cureus. 2021. PMID: 34722077 Free PMC article.
-
[Eales' disease].J Fr Ophtalmol. 2016 May;39(5):474-82. doi: 10.1016/j.jfo.2016.03.001. Epub 2016 May 13. J Fr Ophtalmol. 2016. PMID: 27185661 Review. French.
-
[Eales].J Fr Ophtalmol. 2001 Nov;24(9):984-6. J Fr Ophtalmol. 2001. PMID: 11912845 Review. French.
Cited by
-
Uveitic macular oedema in ocular tuberculosis patients in a non-endemic country: characteristics, management, and visual Outcomes.Eye (Lond). 2025 Feb;39(3):593-601. doi: 10.1038/s41433-024-03577-1. Epub 2025 Jan 7. Eye (Lond). 2025. PMID: 39774294
-
A Review of Eales' Disease and Mycobacterium tuberculosis.Biology (Basel). 2024 Jun 20;13(6):460. doi: 10.3390/biology13060460. Biology (Basel). 2024. PMID: 38927340 Free PMC article. Review.
References
-
- Raizada K., Tripathy K. StatPearls Internet. StatPearls Publishing; Treasure Island, FL, USA: 2023. Eales Disease. - PubMed
-
- Madhavan H., Therese K., Gunisha P., Jayanthi U., Biswas J. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales’ disease. Investig. Ophthalmol. Vis. Sci. 2000;41:822–825. - PubMed
Publication types
LinkOut - more resources
Full Text Sources